Capital Fund Management S.A. Blueprint Medicines Corp Transaction History
Capital Fund Management S.A.
- $33.7 Billion
- Q2 2024
A detailed history of Capital Fund Management S.A. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Capital Fund Management S.A. holds 53,236 shares of BPMC stock, worth $4.79 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
53,236
Previous 11,100
379.6%
Holding current value
$4.79 Million
Previous $1.05 Million
445.34%
% of portfolio
0.02%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$598 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$588 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$529 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$291 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$221 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.37B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...